CD19 and glioblastoma: Patient-derived primary GBM cells with lentiviral wasabi green fluorescent labeling were co-cultured with GD2-specific 4SCAR-T cells, control PBMCs, and non-specific 4SCAR-T cells (CD19) to assess their killing capacity (Fig. 2B).